Cardiac xenotransplantation : Recent preclinical progress with 3-month median survival
暂无分享,去创建一个
Keiji Oi | Walter K Kremers | W. Kremers | H. Tazelaar | C. McGregor | Henry D Tazelaar | Christopher G A McGregor | William R Davies | Sumeet S Teotia | Johannes M Schirmer | Jack M Risdahl | Randall C Walker | Guerard W Byrne | John S Logan | R. Walker | W. Davies | J. Schirmer | G. Byrne | J. Logan | K. Oi | J. Risdahl | S. Teotia | Guerard W Walker | John S Byrne | M. Logan | Jack M Schirmer | Henry D Risdahl | Walter K Tazelaar | Randall C Kremers | G. A. Christopher | William R Mcgregor | Keiji Davies | Sumeet S Oi | Johannes Teotia
[1] T. Larson,et al. Overcoming a Positive Crossmatch in Living‐Donor Kidney Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] F. Bach,et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. , 1997, Transplantation.
[3] R. Lechler,et al. Complete Inhibition of Acute Humoral Rejection Using Regulated Expression of Membrane‐tethered Anticoagulants on Xenograft Endothelium , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] D. Sachs,et al. COAGULATION AND THROMBOTIC DISORDERS ASSOCIATED WITH PIG ORGAN AND HEMATOPOIETIC CELL TRANSPLANTATION IN NONHUMAN PRIMATES , 2000, Transplantation.
[5] J. Platt,et al. Transplantation of discordant xenografts: a challenge revisited. , 1996, Immunology today.
[6] W. Hancock. Delayed Xenograft Rejection , 1997, World Journal of Surgery.
[7] M. Goddard,et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. , 1999, Transplantation proceedings.
[8] R. Colvin,et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. , 1998, Transplantation.
[9] H. Dintzis,et al. Evaluation of different α-galactosyl glycoconjugates for use in xenotransplantation , 2002 .
[10] H. Dintzis,et al. Evaluation of different alpha-Galactosyl glycoconjugates for use in xenotransplantation. , 2002, Bioconjugate chemistry.
[11] J. Platt,et al. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. , 2000, Transplantation.
[12] W. Kremers,et al. Warfarin or Low‐Molecular‐Weight Heparin Therapy does not Prolong Pig‐To‐Primate Cardiac Xenograft Function , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] R. Evans,et al. The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. , 1992, JAMA.
[14] R. Lechler,et al. The cellular rejection of xenografts – recent insights , 2003, Xenotransplantation.
[15] R. Michler,et al. Technique for Primate Heterotopic Cardiac Xenotransplantation , 1985, Journal of medical primatology.
[16] Junzheng Peng,et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. , 1998, Transplantation.
[17] N. Mueller,et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.
[18] R. Pierson,et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] R. Morris,et al. Anti‐non‐Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF‐transgenic porcine hearts in cynomolgus monkeys , 2004, Xenotransplantation.
[20] L. Stevenson,et al. Management of end-stage heart disease , 1998 .
[21] J. Platt,et al. Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. , 1997, Human immunology.
[22] N. Mueller,et al. Suppression of Natural and Elicited Antibodies in Pig‐to‐Baboon Heart Transplantation Using a Human Anti‐Human CD154 mAb‐Based Regimen , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] S. Grey,et al. Expression of human thrombomodulin cofactor activity in porcine endothelial cells. , 1998, Transplantation.
[24] C. Bordignon. Progress Towards the Clinical Application of Somatic Cell Gene Therapy , 1993 .
[25] J. Platt,et al. A HUMAN CD46 TRANSGENIC PIG MODEL SYSTEM FOR THE STUDY OF DISCORDANT XENOTRANSPLANTATION , 2001, Transplantation.
[26] A. B. Stewart,et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. , 2000, Transplantation.
[27] A. Dalmasso,et al. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. , 1998, Transplantation.
[28] H. Tazelaar,et al. Cardiac Xenotransplantation: Progress Toward the Clinic , 2004, Transplantation.
[29] D. Adams,et al. Technique for heterotopic pig heart xenotransplantation in primates. , 1999, The Annals of thoracic surgery.
[30] H. Tazelaar,et al. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival , 2004, Xenotransplantation.
[31] H. Schuurman,et al. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors , 2002, Transplantation.
[32] R. Colvin,et al. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. , 2001, Transplantation.
[33] J. Platt,et al. Acute vascular rejection , 1998, Transplantation proceedings.
[34] D. Cooper,et al. An investigation of the specificity of induced anti‐pig antibodies in baboons , 2003, Xenotransplantation.
[35] J. Platt,et al. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. , 1997, Transplantation proceedings.
[36] D. Sachs,et al. Depletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columns , 1998 .
[37] J. Platt,et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. , 1997, Transplantation.
[38] J. Platt,et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury , 1995, Nature Medicine.
[39] H. Tazelaar,et al. Prevention, detection, and management of early bacterial and fungal infections in a preclinical cardiac xenotransplantation model that achieves prolonged survival , 2005, Xenotransplantation.
[40] D. Sachs,et al. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti‐αGal antibody in the baboon , 1998, Xenotransplantation.
[41] D. Adams,et al. Analysis of the control of the anti-gal immune response in a non-human primate by galactose &agr;1-3 galactose trisaccharide-polyethylene glycol conjugate , 2002, Transplantation.
[42] J. Logan. Prospects for xenotransplantation. , 2000, Current opinion in immunology.
[43] R. Oriol,et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. , 1993, Transplant immunology.